Editorials

Functional dysphonia

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7012.1039 (Published 21 October 1995) Cite this as: BMJ 1995;311:1039
  1. Janet A Wilson,
  2. Ian J Deary,
  3. Shonagh Scott,
  4. Kenneth MacKenzie
  1. Professor Department of Otolaryngology Head and Neck Surgery, Freeman Hospital, Newcastle upon Tyne NE7 7DN
  2. Professor Department of Psychology, University of Edinburgh, Edinburgh EH8 9JZ
  3. Research associate Consultant Department of Otolaryngology and Head and Neck Surgery, Royal Infirmary, Glasgow G31 2ER

    Not “hysterical” but still seen mainly in women

    Last year at the Glasgow Royal Infirmary over 190 new patients presented with dysphonia (hoarseness) and were referred to speech and language therapists for voice therapy. Extrapolation from these data suggests that up to 40000 such patients are referred and treated annually in Britain. A substantial proportion suffer from functional dysphonia, in which there is neither a structural abnormality of the larynx (such as a vocal cord polyp, nodule, or papilloma) nor paralysis. As with most functional somatic symptoms, women are considerably overrepresented, in some series by a factor of eight.1

    Functional dysphonia is a diagnosis of exclusion. It may be confirmed only after specialist examination of the larynx by an otolaryngologist, which means that otolaryngologists see large numbers of patients with functional dysphonia in their outpatient practice. Traditional teaching dictates that hoarseness should remain “unexplained” for only three weeks, especially in smokers.

    General practitioners, however, are aware that laryngeal cancer is rare and found predominantly in older …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe